UK-based AstraZeneca’s acquired rare disease drug has met the primary endpoint in a Phase III trial in patients with chronic ...

The convergence of AI and drug delivery is opening new frontiers in precision medicine. AI-powered predictive modeling is ...

Mycobacterium abscessus is a fast-growing, pathogenic mycobacteria that can cause lung infections, and people who have ...

Johnson & Johnson will stop late-stage studies of its experimental drug to treat major depressive disorder due to a lack of ...

A new fully automated in vivo screening system (AISS) has been developed to transform drug evaluation by enabling rapid, ...

Scientists have called on pharmacists to prioritise research and ethical practice over immediate financial gain, stressing that the cornerstone of effective pharmacy practice lies in rigorous ...

FDA-approved drugs are also often patented and subject to various laws regarding exclusivity for a given manufacturer. At the ...

Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...

The field of cancer treatment has long struggled with the immense costs and time-consuming nature of drug development.

Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...

HUMACAO, PUERTO RICO AND NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or ...